Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk
Psoriasis is an inflammatory skin disease characterized by keratinocyte hyperproliferation with effective environmental and genetic factors. Recent studies showing that the IL-23/IL-17 axis plays a central role in the pathogenesis of the disease. Experimental and clinical studies suggest that IL-17A...
Gespeichert in:
| Veröffentlicht in: | Archives of dermatological research 2022-12, Vol.314 (10), p.937-942 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 942 |
|---|---|
| container_issue | 10 |
| container_start_page | 937 |
| container_title | Archives of dermatological research |
| container_volume | 314 |
| creator | Akşan, Burak Akadam-Teker, Ayşegül Başak |
| description | Psoriasis is an inflammatory skin disease characterized by keratinocyte hyperproliferation with effective environmental and genetic factors. Recent studies showing that the IL-23/IL-17 axis plays a central role in the pathogenesis of the disease. Experimental and clinical studies suggest that
IL-17A
, an important regulatory effector cytokine in this pathway and triggers changes mainly in affected tissues. Based on the central role of
IL-17A
in the pathogenesis of psoriasis, we thought that variations in this gene could affect the susceptibility and severity of this disease. Therefore, in this study, we aimed to analyze whether
IL-17A
rs10484879 variant has an effect on psoriasis pathogenesis in Turkish population. In this case–control study, the study group consisting of 564 patient (188 psoriasis patients (66 males/122 females)/376 controls (132 males/244 females) and they were genotyped in terms of
IL-17A
(rs10484879) polymorphism with TaqMan 5 'Allelic Discrimination Test.
IL-17A
serum levels were measured with the Enzyme-linked immunosorbent assay (ELISA). The genotype distributions of the
IL-17A
rs10484879 polymorphism between the patient and control groups were statistically different in the TT genotype and it was observed more commonly in the patient group compared to the controls (
p
GT > GG in all study groups (
p
|
| doi_str_mv | 10.1007/s00403-021-02308-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2605597416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2719458686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-8bbdc0be7a503954cd4047b5e1939fb1e091ed1069e07f830f3405151a8aa1ee3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoso-PkHPAW8eKnONMkmPYr4BQteFLyFtJ1qtNuuma6L_96sqygePITJ4XleZt4sO0Q4QQBzygAKZA4FpifB5suNbAeVLHKYlA-bv_7b2S7zMyTJWNzJ6ivqaQy1ePMx-H5kEXpxM83RnInICMoqa0rh-0YwxcVMdPRGHYuh_aZ8JOGZhzr4kRqxDOOTmPOQ0jiwiIFf9rOt1ndMB19zL7u_vLg7v86nt1c352fTvJa6GHNbVU0NFRmvQZZa1Y0CZSpNWMqyrZCgRGowHUFgWiuhlQo0avTWeySSe9nxOnceh9cF8ehmgWvqOt_TsGBXTEDr0iicJPToD_o8LGKftnOFwVJpO7ErqlhTdRyYI7VuHsPMx3eH4Fa9u3XvLvXuPnt3yyTJtcQJ7h8p_kT_Y30AQV6DHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2719458686</pqid></control><display><type>article</type><title>Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk</title><source>Springer Nature - Complete Springer Journals</source><creator>Akşan, Burak ; Akadam-Teker, Ayşegül Başak</creator><creatorcontrib>Akşan, Burak ; Akadam-Teker, Ayşegül Başak</creatorcontrib><description>Psoriasis is an inflammatory skin disease characterized by keratinocyte hyperproliferation with effective environmental and genetic factors. Recent studies showing that the IL-23/IL-17 axis plays a central role in the pathogenesis of the disease. Experimental and clinical studies suggest that
IL-17A
, an important regulatory effector cytokine in this pathway and triggers changes mainly in affected tissues. Based on the central role of
IL-17A
in the pathogenesis of psoriasis, we thought that variations in this gene could affect the susceptibility and severity of this disease. Therefore, in this study, we aimed to analyze whether
IL-17A
rs10484879 variant has an effect on psoriasis pathogenesis in Turkish population. In this case–control study, the study group consisting of 564 patient (188 psoriasis patients (66 males/122 females)/376 controls (132 males/244 females) and they were genotyped in terms of
IL-17A
(rs10484879) polymorphism with TaqMan 5 'Allelic Discrimination Test.
IL-17A
serum levels were measured with the Enzyme-linked immunosorbent assay (ELISA). The genotype distributions of the
IL-17A
rs10484879 polymorphism between the patient and control groups were statistically different in the TT genotype and it was observed more commonly in the patient group compared to the controls (
p
< 0.001). Similarly, the T allele was observed with a higher prevalence in the patient group compared to the controls (
p
= 0.007).
IL-17A
serum levels were associated with increased serum concentration, respectively, TT > GT > GG in all study groups (
p
< 0.05). We would like to report that
IL-17A
rs10484879 TT genotype and T allele are associated with increased risk of psoriasis in the Turkish population.</description><identifier>ISSN: 1432-069X</identifier><identifier>ISSN: 0340-3696</identifier><identifier>EISSN: 1432-069X</identifier><identifier>DOI: 10.1007/s00403-021-02308-w</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Alleles ; Dermatology ; Enzyme-linked immunosorbent assay ; Gene polymorphism ; Genetic diversity ; Genetic factors ; Genotype & phenotype ; Interleukin 17 ; Interleukin 23 ; Medicine ; Medicine & Public Health ; Original Paper ; Pathogenesis ; Patients ; Polymorphism ; Population genetics ; Psoriasis ; Serum levels ; Skin diseases</subject><ispartof>Archives of dermatological research, 2022-12, Vol.314 (10), p.937-942</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-8bbdc0be7a503954cd4047b5e1939fb1e091ed1069e07f830f3405151a8aa1ee3</citedby><cites>FETCH-LOGICAL-c352t-8bbdc0be7a503954cd4047b5e1939fb1e091ed1069e07f830f3405151a8aa1ee3</cites><orcidid>0000-0002-3052-5014 ; 0000-0003-3618-0560</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00403-021-02308-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00403-021-02308-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids></links><search><creatorcontrib>Akşan, Burak</creatorcontrib><creatorcontrib>Akadam-Teker, Ayşegül Başak</creatorcontrib><title>Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk</title><title>Archives of dermatological research</title><addtitle>Arch Dermatol Res</addtitle><description>Psoriasis is an inflammatory skin disease characterized by keratinocyte hyperproliferation with effective environmental and genetic factors. Recent studies showing that the IL-23/IL-17 axis plays a central role in the pathogenesis of the disease. Experimental and clinical studies suggest that
IL-17A
, an important regulatory effector cytokine in this pathway and triggers changes mainly in affected tissues. Based on the central role of
IL-17A
in the pathogenesis of psoriasis, we thought that variations in this gene could affect the susceptibility and severity of this disease. Therefore, in this study, we aimed to analyze whether
IL-17A
rs10484879 variant has an effect on psoriasis pathogenesis in Turkish population. In this case–control study, the study group consisting of 564 patient (188 psoriasis patients (66 males/122 females)/376 controls (132 males/244 females) and they were genotyped in terms of
IL-17A
(rs10484879) polymorphism with TaqMan 5 'Allelic Discrimination Test.
IL-17A
serum levels were measured with the Enzyme-linked immunosorbent assay (ELISA). The genotype distributions of the
IL-17A
rs10484879 polymorphism between the patient and control groups were statistically different in the TT genotype and it was observed more commonly in the patient group compared to the controls (
p
< 0.001). Similarly, the T allele was observed with a higher prevalence in the patient group compared to the controls (
p
= 0.007).
IL-17A
serum levels were associated with increased serum concentration, respectively, TT > GT > GG in all study groups (
p
< 0.05). We would like to report that
IL-17A
rs10484879 TT genotype and T allele are associated with increased risk of psoriasis in the Turkish population.</description><subject>Alleles</subject><subject>Dermatology</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Gene polymorphism</subject><subject>Genetic diversity</subject><subject>Genetic factors</subject><subject>Genotype & phenotype</subject><subject>Interleukin 17</subject><subject>Interleukin 23</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Paper</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Polymorphism</subject><subject>Population genetics</subject><subject>Psoriasis</subject><subject>Serum levels</subject><subject>Skin diseases</subject><issn>1432-069X</issn><issn>0340-3696</issn><issn>1432-069X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoso-PkHPAW8eKnONMkmPYr4BQteFLyFtJ1qtNuuma6L_96sqygePITJ4XleZt4sO0Q4QQBzygAKZA4FpifB5suNbAeVLHKYlA-bv_7b2S7zMyTJWNzJ6ivqaQy1ePMx-H5kEXpxM83RnInICMoqa0rh-0YwxcVMdPRGHYuh_aZ8JOGZhzr4kRqxDOOTmPOQ0jiwiIFf9rOt1ndMB19zL7u_vLg7v86nt1c352fTvJa6GHNbVU0NFRmvQZZa1Y0CZSpNWMqyrZCgRGowHUFgWiuhlQo0avTWeySSe9nxOnceh9cF8ehmgWvqOt_TsGBXTEDr0iicJPToD_o8LGKftnOFwVJpO7ErqlhTdRyYI7VuHsPMx3eH4Fa9u3XvLvXuPnt3yyTJtcQJ7h8p_kT_Y30AQV6DHQ</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Akşan, Burak</creator><creator>Akadam-Teker, Ayşegül Başak</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3052-5014</orcidid><orcidid>https://orcid.org/0000-0003-3618-0560</orcidid></search><sort><creationdate>20221201</creationdate><title>Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk</title><author>Akşan, Burak ; Akadam-Teker, Ayşegül Başak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-8bbdc0be7a503954cd4047b5e1939fb1e091ed1069e07f830f3405151a8aa1ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alleles</topic><topic>Dermatology</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Gene polymorphism</topic><topic>Genetic diversity</topic><topic>Genetic factors</topic><topic>Genotype & phenotype</topic><topic>Interleukin 17</topic><topic>Interleukin 23</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Paper</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Polymorphism</topic><topic>Population genetics</topic><topic>Psoriasis</topic><topic>Serum levels</topic><topic>Skin diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akşan, Burak</creatorcontrib><creatorcontrib>Akadam-Teker, Ayşegül Başak</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of dermatological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akşan, Burak</au><au>Akadam-Teker, Ayşegül Başak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk</atitle><jtitle>Archives of dermatological research</jtitle><stitle>Arch Dermatol Res</stitle><date>2022-12-01</date><risdate>2022</risdate><volume>314</volume><issue>10</issue><spage>937</spage><epage>942</epage><pages>937-942</pages><issn>1432-069X</issn><issn>0340-3696</issn><eissn>1432-069X</eissn><abstract>Psoriasis is an inflammatory skin disease characterized by keratinocyte hyperproliferation with effective environmental and genetic factors. Recent studies showing that the IL-23/IL-17 axis plays a central role in the pathogenesis of the disease. Experimental and clinical studies suggest that
IL-17A
, an important regulatory effector cytokine in this pathway and triggers changes mainly in affected tissues. Based on the central role of
IL-17A
in the pathogenesis of psoriasis, we thought that variations in this gene could affect the susceptibility and severity of this disease. Therefore, in this study, we aimed to analyze whether
IL-17A
rs10484879 variant has an effect on psoriasis pathogenesis in Turkish population. In this case–control study, the study group consisting of 564 patient (188 psoriasis patients (66 males/122 females)/376 controls (132 males/244 females) and they were genotyped in terms of
IL-17A
(rs10484879) polymorphism with TaqMan 5 'Allelic Discrimination Test.
IL-17A
serum levels were measured with the Enzyme-linked immunosorbent assay (ELISA). The genotype distributions of the
IL-17A
rs10484879 polymorphism between the patient and control groups were statistically different in the TT genotype and it was observed more commonly in the patient group compared to the controls (
p
< 0.001). Similarly, the T allele was observed with a higher prevalence in the patient group compared to the controls (
p
= 0.007).
IL-17A
serum levels were associated with increased serum concentration, respectively, TT > GT > GG in all study groups (
p
< 0.05). We would like to report that
IL-17A
rs10484879 TT genotype and T allele are associated with increased risk of psoriasis in the Turkish population.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00403-021-02308-w</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3052-5014</orcidid><orcidid>https://orcid.org/0000-0003-3618-0560</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1432-069X |
| ispartof | Archives of dermatological research, 2022-12, Vol.314 (10), p.937-942 |
| issn | 1432-069X 0340-3696 1432-069X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2605597416 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Alleles Dermatology Enzyme-linked immunosorbent assay Gene polymorphism Genetic diversity Genetic factors Genotype & phenotype Interleukin 17 Interleukin 23 Medicine Medicine & Public Health Original Paper Pathogenesis Patients Polymorphism Population genetics Psoriasis Serum levels Skin diseases |
| title | Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A38%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20variants%20in%20IL-17A%20rs10484879%20and%20serum%20levels%20of%20IL-17A%20are%20associated%20with%20psoriasis%20risk&rft.jtitle=Archives%20of%20dermatological%20research&rft.au=Ak%C5%9Fan,%20Burak&rft.date=2022-12-01&rft.volume=314&rft.issue=10&rft.spage=937&rft.epage=942&rft.pages=937-942&rft.issn=1432-069X&rft.eissn=1432-069X&rft_id=info:doi/10.1007/s00403-021-02308-w&rft_dat=%3Cproquest_cross%3E2719458686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2719458686&rft_id=info:pmid/&rfr_iscdi=true |